CD14-dependent innate immunity-mediated neuronal damage in vivo suppressed by NSAIDs and ablation of a prostaglandin E2 receptor, EP2

Current Medicinal Chemistry - Central Nervous System Agents

Volumn 5, Issue 2, 2005, Pages 151-156

  Milatovic, D ^a   Zaja Milatovic, S ^a   Montine, K S ^a   Nivison, M ^a   Montine, T J ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

CD14; Dendrites; Innate immunity; Neurodegeneration; Oxidative damage

Indexed keywords

ACETYLSALICYLIC ACID; AMYLOID BETA PROTEIN; ANTIGEN; CD14 ANTIGEN; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; ISOPROSTANE DERIVATIVE; LIGAND; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR EP1; PROSTAGLANDIN E RECEPTOR EP2; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; AUTISM; BRAIN ISCHEMIA; CEREBRAL PALSY; CLINICAL TRIAL; DEMENTIA; DISEASE MODEL; DRUG EFFECT; DRUG EXPOSURE; GLIA; HEAD INJURY; HUMAN; INNATE IMMUNITY; MULTIPLE SCLEROSIS; NERVE CELL LESION; NERVE FIBER DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATION; PARACRINE SIGNALING; REVIEW; STROKE;

EID: 20444503435     PISSN: 15680150     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568015054022362     Document Type: Review

References (57)

1. Polazzi, E.; Contestabile, A. Rev. Neurosci., 2002, 13, 221.
2. Vargas, D.L.; Nascimbene, C.; Krishnan, C.; Zimmerman, A.W.; Pardo, C.A. Ann. Neurol., 2005, 57, 67.
3. Stern, E.L.; Quan, N.; Proescholdt, M.G.; Herkenham, M. J. Neuroimmunol. 2000, 106, 114.
4. Montine, T.J.; Milatovic, D.; Gupta, R.C.; Valyi-Nagy, T.; Morrow, J.D.; Breyer, R.M. J. Neurochem., 2002, 83, 463.
5. Nadeau, S.; Rivest, S. J. Immunol., 2002, 169, 3370.
6. Nadeau, S.; Rivest, S. J. Neurosci., 2003, 23, 5536.
7. Milatovic, D.; Zaja-Milatovic, S.; Montine, K.S.; Homer, P.J.; Montine, T.J. J. Neurochem., 2003, 87, 1518.
8. Rosi, S.; Ramirez-Amaya, V.; Hauss-Wegrzyniak, B.; Wenk, G.L. J. Neuroinflammation., 2004, 1, 12.
9. Imler, J.L.; Hoffmann, J.A. Trends Cell Biol., 2001, 11, 304.
10. Akira, S. J. Biol. Chem., 2003, 278, 38105.
11. Palsson-McDermott, E.M.; O'Neill, L.A. Immunology, 2004, 113, 153.
12. Hata, A.N.; Breyer, R.M. Pharmacol. Ther., 2004, 103, 147.
13. Johnson, G.B.; Brunn, G.J.; Platt, J.L. Crit. Rev. Immunol., 2003, 23, 15.
14. Cook, D.N.; Pisetsky, D.S.; Schwartz, D.A. Nat. Immunol., 2004, 5, 975.
15. Fassbender, K.; Walter, S.; Kuhl, S.; Landmann, R.; Ishii, K.; Bertsch, T.; Stalder, A.K.; Muehlhauser, F.; Liu, Y.; Ulmer, A.J.; Rivest, S.; Lentschat, A.; Gulbins, E.; Jucker, M.; Staufenbiel, M.; Brechtel, K.; Walter, J.; Multhaup, G.; Penke, B.; Adachi, Y.; Hartmann, T.; Beyreuther, K. FASEB J., 2004, 18, 203.
16. Moffatt, O.D.; Devitt, A.; Bell, E.D.; Simmons, D.L.; Gregory, C.D. J. Immunol., 1999, 162, 6800.
17. Lee, H.G.; Moreira, P.I.; Zhu, X.; Smith, M.A.; Perry, G. Am. J. Pathol., 2004, 165, 1461.
18. Pratico, D.; Clark, C.M.; Liun, F.; Lee, V.Y.-M.; Trojanowski, J.Q. Arch Neurol., 2002, 59, 972.
19. Minghetti, L.; Levi, G. J. Neurochem., 1995, 65, 2690.
20. Fiebich, B.L.; Schleicher, S.; Spleiss, O.; Czygan, M.; Hull, M. J. Neurochem., 2001, 79, 950.
21. Liu, B.; Gao, H.M.; Wang, J.Y.; Jeohn, G.H.; Cooper, C.L.; Hong, J.S. Ann. N.Y. Acad. Sci., 2002, 902, 318.
22. Xie, Z.; Wei, M.; Morgan, T.E.; Fabrizio, P.; Han, D.; Finch, C.E.; Longo, V.D. J. Neurosci.. 2002, 22, 3484.
23. Rivest, S. Brain Behav. Immun., 2003, 17, 13.
24. Beschorner, R.; Nguyen, T.D.; Gozalan, F.; Pedal, I.; Mattern, R.; Schluesener, H.J.; Meyermann, R.; Schwab, J.M. Acta Neuropathol. (Berl), 2002, 103, 541.
25. Lehnardt, S.; Massillon, L.; Follett, P.; Jensen, F.E.; Ratan, R.; Rosenberg, P.A.; Volpe, J.J.; Vartanian, T. Proc. Natl. Acad. Sci. USA, 2003, 100, 8514.
26. Sugimoto, Y.; Shigemoto, R.; Namba, T.; Negishi, M.; Mizuno, N.; Narumiya, S.; Ichikawa, A. Neuroscience, 1994, 62, 919.
27. Dumont, I.; Peri, K.G.; Hardy, P.; Hou, X.; Martinez-Bermudez, A.K.; Molotchnikoff, S.; Varma, D.R.; Chemtob, S. Am. J. Physiol., 1998, 275, R1812.
28. Zhang, J.; Rivest, S. Eur. J. Neurosci., 1999, 11, 2651.
29. Ek, M.; Arias, C.; Sawchenko, P.; Ericsson-Dahlstrand, A. J. Comp. Neurol., 2000, 428, 5-20.
30. Nakamura, K.; Kaneko, T.; Yamashita, Y.; Hasegawa, H.; Katoh, H.; Negishi, M. J. Comp. Neurol., 2000, 421, 543-569.
31. McCullough, L.; Wu, L.; Haughey, N.; Liang, X.; Hand, T.; Wang, Q.; Breyer, R.M.; Andreasson, K. J. Neurosci., 2004, 24, 257.
32. Insel, P.A. In Goodman and Gilman's The Pharmacological Basis of Therapeutics; J.G. Hardman and L.E. Limbird, Eds. McGraw-Hill: New York, 1996; pp. 617.
33. Weggen, S.; Eriksen, J.L.; Das, P.; Sagi, S.A.; Wang, R.; Pietrzik, C.U.; Findlay, K.A.; Smith, T.E.; Murphy, M.P.; Bulter, T.; Kang, D.E.; Marquez-Sterling, N.; Golde, T.E.; Koo, E.H. Nature, 2001, 414, 212.
34. Lanz, T.A.; Fici, G.J.; Merchant, K.M. J. Pharmacol. Exp. Ther., 2005, 312, 399.
35. Etminan, M.; Gill, S.; Samii, A. BMJ, 2003, 327, 128.
36. Montine, T.J.; Sidell, K.S.; Crews, B.C.; Markesbery, W.R.; Marnett, L.J.; Roberts, L.J.; Morrow, J.D. Neurology, 1999, 53, 1495.
37. Griffin, D.E.; Wesselingh, S.L.; McArthur, J.C. Ann. Neurol., 1994, 35, 592.
38. Breyer, R.M.; Bagdassarian, C.K.; Myers, S.A.; Breyer, M.D. Ann. Rev. Pharmacol. Toxicol., 2001, 41, 661.
39. Bhattacharya, M.; Peri, K.; Almazan, G.; Ribeiro-da-Silva, A.; Shichi, H.; Durocher, Y.; Abramovitz, M.; Hou, X.; Varma, D.; Chemtob, S. Proc. Natl. Acad. Sci. USA, 1998, 95, 15792.
40. Oka, T.; Oka, K.; Schammell, T.E.; Lee, C.; Kelly, J.F.; Nantel, F.; Elmquist, J.K.; Saper, C.B. J. Comp. Neurol., 2000, 428, 20.
41. Drachmen, D.; Rothstein, J. Ann. Neurol., 2000, 48, 792.
42. Minghetti, L.; Polazzi, E.; Nicolini, A.; Creminon, C.; Levi, G. Eur. J. Neurosci., 1997, 9, 934.
43. Caggiano, A.O.; Kraig, R.P. J. Neurochem., 1999, 72, 565.
44. Levi, G.; Minghetti, L.; Aloisi, F. Biochimie, 1998, 80, 899-904
45. Hardy, J.; Selkoe, D.J. Science, 2002, 297, 353.
46. Kelley, K.; Ho, L.; Winger, D.; Freire-Moar, J.; Borelli, C.; Aisen, P.; Pasinetti, G. Am. J. Pathol., 1999, 155, 995.
47. Aloisi, F.; DeSimone, R.; Columba-Cabezas, S.; Levi, G. J. Neurosci. Res., 1999, 56, 571.
48. Minghetti, L.; Nicolini, A.; Polazzi, E.; Creminon, C.; Maclouf, J.; Levi, G. Glia, 19, 1997, 19, 152.
49. Minghetti, L.; Polazzi, E.; Nicolini, A.; Levi, G. J. Neuroimmunol., 1998, 82, 31.
50. Sanzgiri, R.; Araque, A.; Haydon, P. J. Neurobiol., 1999, 41, 221.
51. Caggiano, A.; Kraig, R. J. Neurochem., 1998, 70, 2357.
52. Hewett, S.; Uliasz, T.; Vidwans, A.; Hewett, J. J. Pharm. Exp. Ther., 2000, 293, 417.
53. Cazevielle, C.; Muller, A.; Meynier, F.; Dutrait, N.; Bonne, C. Neurochem. Int., 1994, 24, 395.
54. Akaike, A.; Kaneko, S.; Tamura, Y.; Nakata, N.; Shiomi, H.; Narumiya, S. Brain Res., 1994, 663, 237.
55. Bezzi, P.; Carmignoto, G.; Pasti, L.; Vesce, S.; Rossi, D.; Rizzini, B.L.; Pozzan, T.; Volterra, A. Nature. 1998, 391, 281.
56. Paoletti, A.; Piccirilli, S.; Costa, N.; Rotiroti, D.; Bagetta, G.; Nistico, G. Exp. Neurol., 1998, 149, 349.
57. Thornhill, J.; Smith, M. Brain Res., 1998, 784, 48.